PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
Drug Abuse		Disease	Target	CAMK2B
Hearing Loss		Disease	Target	CAMK2B
Carcinoma		Disease	Target	AMY2B
Carcinoma		Disease	Target	CAMK1D
Carcinoma		Disease	Target	DJ-1/PARK7
Eczema		Disease	Disease	Cradle Cap
Depression		Disease	Target	CAMK2D
Depression		Disease	Target	CAMK2B
Diaper Rash		Disease	Disease	Cradle Cap
Cancer		Disease	Target	AMY2B
Cancer		Disease	Target	CAMK1D
Cancer		Disease	Drug	Alefacept (Amevive)- FDA
Cancer		Disease	Target	CAMK2D
Cancer		Disease	Drug	Amevive (Alefacept)- FDA
Cancer		Disease	Target	CAMK2B
Cancer		Disease	Target	DJ-1/PARK7
Cancer		Disease	Target	Alpha Platelet-Derived Growth Factor Receptor
Parkinsons Disease		Disease	Target	DJ-1/PARK7
Brain Injury		Disease	Target	CAMK2D
Parkinsonism		Disease	Target	DJ-1/PARK7
Ovarian Cancer		Disease	Target	AMY2B
Ovarian Cancer		Disease	Target	CAMK2D
Prostate Cancer		Disease	Target	Alpha Platelet-Derived Growth Factor Receptor
Skin Cancer		Disease	Drug	Alefacept (Amevive)- FDA
Skin Cancer		Disease	Drug	Amevive (Alefacept)- FDA
Inflammatory Bowel Disease		Disease	Target	Protein Fimh
Infection		Disease	Target	CAMK2D
Infection		Disease	Target	Protein Fimh
Stroke		Disease	Target	CAMK1D
Stroke		Disease	Target	CAMK2D
Influenza		Disease	Target	CAMK2B
Influenza		Disease	Target	Protein Fimh
Shock		Disease	Target	DJ-1/PARK7
Arthritis		Disease	Drug	Alefacept (Amevive)- FDA
Arthritis		Disease	Drug	Amevive (Alefacept)- FDA
Respiratory Tract Infections		Disease	Disease	Cradle Cap
Major Depressive Disorder		Disease	Target	CAMK2D
Cholesterol		Disease	Target	CAMK2B
Inflammation		Disease	Target	Protein Fimh
Lung Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Scars		Disease	Drug	Dracorhodin
Diabetes		Disease	Target	BRSK1
Psychiatric Disorder		Disease	Target	Cyclooxygenase-3
Graft Versus Host Disease		Disease	Target	4-1BB Receptor
Obesity		Disease	Target	BRSK1
Carcinoma		Disease	Target	4-1BB Receptor
Carcinoma		Disease	Target	BRSK1
Carcinoma		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Hemorrhage		Disease	Drug	Apresoline (Hydralazine)- FDA
Cancer		Disease	Target	4-1BB Receptor
Cancer		Disease	Target	BRSK1
Cancer		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Cancer		Disease	Drug	Dracorhodin
Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Arrhythmia		Disease	Drug	Apresoline (Hydralazine)- FDA
Prostate Cancer		Disease	Drug	Dracorhodin
Acute Promyelocytic Leukemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Infection		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Stroke		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Glomerulonephritis		Disease	Drug	Apresoline (Hydralazine)- FDA
Renal Failure		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Diabetic Nephropathy		Disease	Drug	Dracorhodin
Anemia		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Anemia		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Cholesterol		Disease	Drug	Ascorbic Acid (Vitamin C)- FDA
Hepatitis		Disease	Drug	Apresoline (Hydralazine)- FDA
Myelodysplastic Syndrome		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Syphilis		Disease	Drug	Apresoline (Hydralazine)- FDA
Breast Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Lung Cancer		Disease	Drug	Aranesp (Darbepoetin Alfa)- FDA
Colon Cancer		Disease	Target	Complement Decay-Accelerating Factor
Skin Disease		Disease	Target	Eotaxin-2/CCL24
Lung Cancer		Disease	Drug	Kaad-Cyclopamine
Lung Cancer		Disease	Target	Kallikrein-8
Non Small Cell Lung Cancer		Disease	Target	Kallikrein-8
Diabetes		Disease	Drug	Kaad-Cyclopamine
Diabetes		Disease	Target	464.1
Diabetes		Disease	Target	ALK Phos
Graft Versus Host Disease		Disease	Target	AMAC-1
Poisoning		Disease	Target	ALK Phos
Chronic Pain		Disease	Target	Mu-Type Opioid Receptor
Carcinoma		Disease	Target	464.1
Carcinoma		Disease	Target	Kallikrein-8
Metastatic Breast Cancer		Disease	Drug	Aralen (Chloroquine)- FDA
Depression		Disease	Target	Mu-Type Opioid Receptor
Osteoarthritis		Disease	Target	ALK Phos
Osteoarthritis		Disease	Target	Kallikrein-8
Cancer		Disease	Drug	Aralen (Chloroquine)- FDA
Cancer		Disease	Target	464.1
Cancer		Disease	Target	ALK Phos
Cancer		Disease	Drug	Amitiza (Lubiprostone)- FDA
Cancer		Disease	Target	Kallikrein-8
Nausea		Disease	Drug	Amitiza (Lubiprostone)- FDA
Ovarian Cancer		Disease	Target	Kallikrein-8
Prostate Cancer		Disease	Target	464.1
Prostate Cancer		Disease	Target	ALK Phos
Prostate Cancer		Disease	Target	Kallikrein-8
Acute Promyelocytic Leukemia		Disease	Target	464.1
Tuberculosis		Disease	Target	Eotaxin-2/CCL24
Brain Cancer		Disease	Target	Kallikrein-8